FDA Inspection 1060498 — Gulf Coast Regional Blood Center At Baytown
The FDA completed an inspection of Gulf Coast Regional Blood Center At Baytown on May 31, 2018 in Baytown, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Baytown, TX (United States)